Abstract
Beta adrenergic antagonists are known to induce psoriasis and psoriasiform eruptions or exacerbate pre-existing psoriasis [3, 5, 8, 11, t 3]. The underlying mechanism is not fully understood. The present study, conducted on patients with psoriasis and psoriasiform eruptions associated with intake of the beta-adrenergic antagonist propranolol, was designed to evaluate immune sensitization towards the
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
